Announcements Trials
Browse Landscape

Clinical Trials

2 trials
RecentStart dateEnrollment
DDMS × Clear all

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Thyroid Nodule 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Cisplatin 3180Cyclophosphamide 3173Carboplatin 2960Radiotherapy 2772Paclitaxel 2708Gemcitabine 2552pembrolizumab 2370Bevacizumab 2195Docetaxel 2191Fluorouracil 1839Capecitabine 1815Oxaliplatin 1724Dexamethasone 1593Nivolumab 1577Doxorubicin 1501Rituximab 1480Magnetic Resonance Spectroscopy 1368Etoposide 1344Irinotecan 1241Leucovorin 1217Drug Therapy 1190Cytarabine 1127Pemetrexed 1068fludarabine 1035Specimen Handling 987Vincristine 964Prednisone 940Cetuximab 939Trastuzumab 937Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT03676647 2026-02-20

Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

City of Hope Medical Center

Recruiting
22 enrolled
Head & Neck

Thyroid Nodule

NCT04690699 2024-10-24

LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

Istari Oncology, Inc.

Phase 1/2 Terminated
4 enrolled 6 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡